Healthcare provider profile · identity verified

Kyi Kyi Thwin Win, MD

Internal Medicine · SONORA, CA · NPI 1083606487

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	679	193
Levothyroxine Sodium	Levothyroxine Sodium	354	100
Losartan Potassium	Losartan Potassium	324	102
Amlodipine Besylate	Amlodipine Besylate	313	95
Lisinopril	Lisinopril	245	74
Gabapentin	Gabapentin	184	61
Omeprazole	Omeprazole	180	59
Spironolactone	Spironolactone	176	52
Potassium Chloride	Potassium Chloride	160	54
Metoprolol Succinate	Metoprolol Succinate	157	49
Ezetimibe	Ezetimibe	131	42
Metformin Hcl	Metformin Hcl	127	38
Rosuvastatin Calcium	Rosuvastatin Calcium	122	41
Ozempic	Semaglutide	106	22
Tamsulosin Hcl	Tamsulosin Hcl	104	40
Meloxicam	Meloxicam	101	34
Simvastatin	Simvastatin	98	30
Furosemide	Furosemide	95	34
Eliquis	Apixaban	91	32
Venlafaxine Hcl Er	Venlafaxine Hcl	89	24
Albuterol Sulfate Hfa	Albuterol Sulfate	88	30
Pantoprazole Sodium	Pantoprazole Sodium	85	30
Duloxetine Hcl	Duloxetine Hcl	82	23
Tramadol Hcl	Tramadol Hcl	81	31
Estradiol	Estradiol	80	23
Carvedilol	Carvedilol	75	23
Zolpidem Tartrate	Zolpidem Tartrate	74	15
Buspirone Hcl	Buspirone Hcl	69	30
Famotidine	Famotidine	69	24
Fluticasone Propionate	Fluticasone Propionate	69	31
Sertraline Hcl	Sertraline Hcl	66	24
Hydrochlorothiazide	Hydrochlorothiazide	65	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	62	19
Trazodone Hcl	Trazodone Hcl	59	19
Celecoxib	Celecoxib	58	20
Alendronate Sodium	Alendronate Sodium	57	16
Atenolol	Atenolol	53	16
Montelukast Sodium	Montelukast Sodium	53	15
Valsartan	Valsartan	53	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	22
Clopidogrel	Clopidogrel Bisulfate	49	14
Jardiance	Empagliflozin	48	16
Pravastatin Sodium	Pravastatin Sodium	48	15
Warfarin Sodium	Warfarin Sodium	42	11
Methylprednisolone	Methylprednisolone	40	31
Synthroid	Levothyroxine Sodium	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	13
Cephalexin	Cephalexin	38	31
Escitalopram Oxalate	Escitalopram Oxalate	38	12
Hydroxyzine Hcl	Hydroxyzine Hcl	38	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	37	12
Bupropion Xl	Bupropion Hcl	36	11
Citalopram Hbr	Citalopram Hydrobromide	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	13
Propranolol Hcl	Propranolol Hcl	34	11
Quetiapine Fumarate	Quetiapine Fumarate	34	11
Memantine Hcl	Memantine Hcl	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	11
Allopurinol	Allopurinol	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Azithromycin	Azithromycin	31	28
Alprazolam	Alprazolam	30	14
Finasteride	Finasteride	28	11
Ibuprofen	Ibuprofen	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	24
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Mirtazapine	Mirtazapine	25	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	16
Lovastatin	Lovastatin	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Prednisone	Prednisone	21	11
Farxiga	Dapagliflozin Propanediol	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Clonidine	Clonidine	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Digoxin	Digoxin	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Testosterone	Testosterone	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error